Stryker, Inari

Stryker's acquisition of Inari for $4.9B enhances its neurovascular portfolio and boosts revenue growth by 50bp, with minimal ...
But Stryker's stock dipped over 2%, as Wall Street wrestled with the $80-per-share valuation and questions about short-term ...
Shares of Inari Medical, Inc. (NASDAQ:NARI – Get Free Report) have received an average rating of “Moderate Buy” from the ...
Inari Medical, Inc. NARI is well-poised for growth on the back of a huge market opportunity for its products and its ...
Stay informed and make data-driven decisions with our Ratings Table. Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous ...